Skip to main content

How to Overcome the Antibiotic Crisis

Facts, Challenges, Technologies and Future Perspectives

  • Book
  • © 2016

Access provided by Autonomous University of Puebla

Overview

  • Broadens the reader’s understanding of the challenges entailed by the threat of an antibiotic crisis
  • Will stimulate future work on urgently needed antibacterial drug discovery
  • Covers both basic and applied aspects

Part of the book series: Current Topics in Microbiology and Immunology (CT MICROBIOLOGY, volume 398)

Buy print copy

Softcover Book USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

About this book

This volume focuses on antibiotics research, a field of topical significance for human health due to the worrying increase of nosocomial infections caused by multi-resistant bacteria. It covers several basic aspects, such as the evolution of antibiotic resistance and the influence of antibiotics on the gut microbiota, and addresses the search for novel pathogenicity blockers as well as historical aspects of antibiotics. Further topics include applied aspects, such as drug discovery based on biodiversity and genome mining, optimization of lead structures by medicinal chemistry, total synthesis and drug delivery technologies. Moreover, the development of vaccines as a valid alternative therapeutic approach is outlined, while the importance of epidemiological studies on important bacterial pathogens, the problems arising from the excessive use of antibiotics in animal breeding, and the development of innovative technologies for diagnosing the “bad bugs” are discussed in detail. Accordingly, the book will appeal to researchers and clinicians alike.

Similar content being viewed by others

Keywords

Table of contents (17 chapters)

Editors and Affiliations

  • Department Microbial Drugs, Helmholtz Centre for Infection Research, Braunschweig, Germany

    Marc Stadler

  • Dept. Molecular Infection Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany

    Petra Dersch

About the editors

Prof. Dr. Marc Stadler and Prof. Dr. Petra DerschHelmholtz Centre for Infection Research, Braunschweig, Germany

Bibliographic Information

Publish with us